Clauser Noah 4
4 · Astria Therapeutics, Inc. · Filed Jun 6, 2023
Insider Transaction Report
Form 4
Clauser Noah
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-06-02+100,000→ 100,000 totalExercise: $13.36Exp: 2033-01-31→ Common Stock (100,000 underlying)
Footnotes (2)
- [F1]This option was by granted effective as of February 1, 2023, subject to stockholder approval of an amendment to Astria Therapeutics, Inc.'s (the "Company") Amended and Restated 2015 Stock Incentive Plan to increase the number of shares available for issuance thereunder by 4,300,000 (the "Stock Plan Amendment Proposal"). The Company's stockholders approved the Stock Plan Amendment Proposal on June 2, 2023.
- [F2]This option is subject to vesting over a four-year period, with 25% of the 100,000 shares underlying the option upon grant vesting on the first anniversary of February 1, 2023 and the remainder vesting over the ensuing three years in equal monthly installments.